Revcovi

elapegadamase-lvlr · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Revcovi, covering 2018-10-05 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Registry Study of Revcovi Treatment in Patients With ADA-SCID